EBUS-TBNA-RTE VS Radiography in Staging of NSCLC
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03392506 |
|
Recruitment Status : Unknown
Verified January 2018 by Jiayuan Sun, Shanghai Chest Hospital.
Recruitment status was: Recruiting
First Posted : January 8, 2018
Last Update Posted : January 8, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Lung Cancer | Device: EBUS-TBNA-RTE | Not Applicable |
The newly developed convex array can be used to identify the hardness of the lymph nodes and estimate the benign and malignant lymph nodes indirectly through the quantitative and visualized analysis of the elastic coefficient of the bronchus through the CP-EBUS elastography mode.
The purpose of this study is to make a qualitative and quantitative analysis of the intrathoracic lymph nodes by CP-EBUS elastography for the first time, and to make a benign and malignant diagnosis.
120cases will be enrolled.Compared with the commonly used methods to evaluate intrathoracic lymph node metastasis, the accuracy of chest CT and PET-CT were compared. The lymph node staging method and the final pathological gold standard of the three groups were compared, so as to verify the accuracy and clinical popularization of the bronchial ultrasound elastography mode.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 120 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Diagnostic |
| Official Title: | A Control Study of Intrathoracic Lymph Node in NSCLC Staging by EBUS-TBNA-RTE and Radiography |
| Actual Study Start Date : | November 28, 2017 |
| Estimated Primary Completion Date : | December 31, 2018 |
| Estimated Study Completion Date : | December 31, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: EBUS-TBNA-RTE
Patients do CT、 PETCT examination and EBUS-TBNA-RTE
|
Device: EBUS-TBNA-RTE
Every patient will do CT、 PETCT and EBUS-TBNA-RTE.These three kind of examination will have their own result.The three methods of inspection will be compared by diagnostic rate |
- The effectiveness of EBUS-TBNA-RTE [ Time Frame: 1year ]By comparison of the diagnostic accuracy of CT ,PET-CT and EBUS-TBNA-RTE
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Intrathoracic lymph node enlargement
- EBUS-TBNA operation can be performed
Exclusion Criteria:
1. Unable to cooperate with the experiment
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03392506
| Contact: Xiaoxuan Zheng, MD | 86-18918169140 | milozheng59@163.com |
| China, Shanghai | |
| Shanghai Chest Hospital | Recruiting |
| Shanghai, Shanghai, China, 200030 | |
| Contact: Jiayuan Sun, MD, PhD 86-18017321598 jysun1976@163.com | |
| Responsible Party: | Jiayuan Sun, Director,Endoscopy Department,Shanghai Chest Hospital, Shanghai Chest Hospital |
| ClinicalTrials.gov Identifier: | NCT03392506 |
| Other Study ID Numbers: |
SHCHE201702 |
| First Posted: | January 8, 2018 Key Record Dates |
| Last Update Posted: | January 8, 2018 |
| Last Verified: | January 2018 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
CP-EBUS EBUS-TBNA Real time elasticity Staging of lung cancer |
|
Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site |
Neoplasms Lung Diseases Respiratory Tract Diseases |

